ACR Convergence 2023 attendees will receive an early review of four papers currently in press at top rheumatology journals.
The Tuesday, Nov. 14, session Editor’s Picks 2023: Arthritis & Rheumatology and Annals of the Rheumatic Diseases will be from 7:30–9 a.m. PT in Room 6F/6C of the San Diego Convention Center. The session will be livestreamed and available on demand within 24 hours for registered ACR Convergence 2023 participants.
“Annals of the Rheumatic Diseases — and also Arthritis & Rheumatology — is interested in innovation, such as new pathogenetic insights, new molecular targets with translational aspects, new therapies, new treatment strategies, or other robust data that inform clinical practice conclusively across the rheumatic disease spectrum. Thus, our wish is to publish only outstanding papers,” said session co-moderator Josef Smolen, MD, Editor-in-Chief of Annals of the Rheumatic Diseases. “For the present session, we were primarily interested to focus on papers that have appeared just very recently, so not earlier during this year or from previous years, and that may elicit particular interest.”
Two titles were chosen from each journal. Featured papers include:
- A Randomized Double-blind Sham-controlled Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis, presented by author Matthew Baker, MD, MS, Stanford University
- Effect of Tapered Versus Stable Treatment with Tumor Necrosis Factor Inhibitors on Disease Flares in Patients with Rheumatoid Arthritis in Remission: A Randomized, Open-Label, Non-Inferiority Trial, presented by author Siri Lillegraven, MD, PhD, MPH, Diakonhjemmet Hospital, Norway
- Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention, presented by author Lihi Eder, MD, PhD, University of Toronto, Canada
- Longitudinal Gut Microbiome Analyses and Blooms of Pathogenic Strains during Lupus Disease Flares, presented by author Gregg Silverman, MD, NYU Grossman School of Medicine
“The audience will come away from the session with new information relevant to their clinical practice,” said co-moderator Daniel H. Solomon, MD, MPH, Editor-in-Chief of Arthritis & Rheumatology. “The information will stimulate conversations that drive the science of rheumatology forward.”
In addition to the cutting-edge science in the papers, the session will provide insight into the editorial process, including article selection.
“Many investigators have questions about the editorial and review processes,” Dr. Solomon said. “The session provides attendees an opportunity to ask the editors-in-chief about the inner workings of rheumatology’s top journals.”
Arthritis & Rheumatology is published by the ACR, and Annals of the Rheumatic Diseases is published by EULAR.